Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study-Reference-Cited by-同舟云学术

Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study

Published:2015-03-25 Issue:9 Volume:35 Page:2155-2166
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Park Joong‐Won¹,Chen Minshan²,Colombo Massimo³,Roberts Lewis R.⁴,Schwartz Myron⁵,Chen Pei‐Jer⁶,Kudo Masatoshi⁷,Johnson Philip⁸,Wagner Samuel⁹,Orsini Lucinda S.¹⁰,Sherman Morris¹¹

Affiliation:

1. Center for Liver Cancer National Cancer Center Goyang Korea

2. Sun Yat‐Sen University Cancer Center Guangzhou China

3. Policlinic IRCCS Maggiore Hospital University of Milan Milan Italy

4. Division of Gastroenterology and Hepatology Mayo Clinic Rochester MN USA

5. Mount Sinai Hospital New York NY USA

6. Taiwan National University Taipei Taiwan

7. Kinki University School of Medicine Osaka‐Sayama Osaka Japan

8. Birmingham University Birmingham UK

9. Bristol‐Myers Squibb Princeton NJ USA

10. Bristol‐Myers Squibb Wallingford CT USA

11. University of Toronto Toronto ON Canada

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.12818

Reference40 articles.

1. FerlayJ SoerjomataramI ErvikM et al.GLOBOCAN 2012 v1.0. Estimated cancer incidence mortality and prevalence worldwide. Available athttp://globocan.iarc.fr. Accessed 28 March 2014.

2. EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

3. Hepatocellular carcinoma

4. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

5. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis

Cited by 920 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular carcinoma;Treatment and Management of Tropical Liver Disease;2025

2. Current research status of transarterial therapies for hepatocellular carcinoma;World Journal of Gastrointestinal Oncology;2024-09-15

3. The combination of ALPPS, interventional hepatoma therapy, targeted therapy, and immunotherapy: A novel conversion therapy model for unresectable HCC;2024-09-08

4. Examining the evolving landscape of liver cancer burden in the United States from 1990 to 2019;BMC Cancer;2024-09-04

5. Simplified Chronic Hepatitis B Antiviral Initiation Criteria in Thailand: An Economic Evaluation;Value in Health Regional Issues;2024-09